Home Healthcare Healthcare Services Fragment-Based Drug Discovery Market

Fragment-Based Drug Discovery Market Size, Share & Trends Analysis Report By Service Components (Fragment Screening, Fragment Optimization), By End-User (Biopharmaceutical Companies, CROs, Academic and Research Institutions), By Applications (Oncology, Central Nervous System (CNS) Disorders, Infectious Diseases, Cardiovascular Diseases, Metabolic Disorders, Inflammation and Autoimmune Diseases) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR422DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Fragment-Based Drug Discovery Market, By Service Components 2022-2034 (USD MILLION/ Units)
    1. Fragment Screening
      1. Biophysical Techniques 
        1. NMR Spectroscopy
        2. DSF Assay 
        3. Fluorescence Polarization (FP)
        4. Isothermal Titration Calorimetry (ITC)
        5. X-ray Crystallography
        6. Surface Plasmon Resonance
        7. Mass Spectrometry
        8. Capillary Electrophoresis
        9. Other Biophysical Techniques, Non-biophysical Techniques)
      2. Non-Biophysical Techniques 
    2. Fragment Optimization 
  2. Fragment-Based Drug Discovery Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Biopharmaceutical Companies
    2. CROs
    3. Academic and Research Institutions
  3. Fragment-Based Drug Discovery Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Central Nervous System (CNS) Disorders
    3. Infectious Diseases
    4. Cardiovascular Diseases
    5. Metabolic Disorders
    6. Inflammation and Autoimmune Diseases
  4. Regional Fragment-Based Drug Discovery Market
    1. North America
      1. North America Fragment-Based Drug Discovery Market By Service Components 2022-2034 (USD MILLION/ Units)
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
      2. North America Fragment-Based Drug Discovery Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. CROs
        3. Academic and Research Institutions
      3. North America Fragment-Based Drug Discovery Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Central Nervous System (CNS) Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Disorders
        6. Inflammation and Autoimmune Diseases
      4. U.S.
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      5. Canada
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
    2. Europe
      1. Europe Fragment-Based Drug Discovery Market By Service Components 2022-2034 (USD MILLION/ Units)
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
      2. Europe Fragment-Based Drug Discovery Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. CROs
        3. Academic and Research Institutions
      3. Europe Fragment-Based Drug Discovery Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Central Nervous System (CNS) Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Disorders
        6. Inflammation and Autoimmune Diseases
      4. U.K.
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      5. Germany
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      6. France
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      7. Spain
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      8. Italy
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      9. Russia
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      10. Nordic
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      11. Benelux
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      12. Rest of Europe
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
    3. APAC
      1. APAC Fragment-Based Drug Discovery Market By Service Components 2022-2034 (USD MILLION/ Units)
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
      2. APAC Fragment-Based Drug Discovery Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. CROs
        3. Academic and Research Institutions
      3. APAC Fragment-Based Drug Discovery Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Central Nervous System (CNS) Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Disorders
        6. Inflammation and Autoimmune Diseases
      4. China
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      5. Korea
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      6. Japan
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      7. India
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      8. Australia
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      9. Singapore
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      10. Taiwan
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      11. South East Asia
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      12. Rest of Asia-Pacific
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
    4. Middle East and Africa
      1. Middle East and Africa Fragment-Based Drug Discovery Market By Service Components 2022-2034 (USD MILLION/ Units)
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
      2. Middle East and Africa Fragment-Based Drug Discovery Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. CROs
        3. Academic and Research Institutions
      3. Middle East and Africa Fragment-Based Drug Discovery Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Central Nervous System (CNS) Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Disorders
        6. Inflammation and Autoimmune Diseases
      4. UAE
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      5. Turkey
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      6. Saudi Arabia
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      7. South Africa
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      8. Egypt
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      9. Nigeria
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      10. Rest of MEA
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
    5. LATAM
      1. LATAM Fragment-Based Drug Discovery Market By Service Components 2022-2034 (USD MILLION/ Units)
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
      2. LATAM Fragment-Based Drug Discovery Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. CROs
        3. Academic and Research Institutions
      3. LATAM Fragment-Based Drug Discovery Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Central Nervous System (CNS) Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Disorders
        6. Inflammation and Autoimmune Diseases
      4. Brazil
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      5. Mexico
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      6. Argentina
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      7. Chile
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      8. Colombia
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
      9. Rest of LATAM
        1. Fragment Screening
          1. Biophysical Techniques 
            1. NMR Spectroscopy
            2. DSF Assay 
            3. Fluorescence Polarization (FP)
            4. Isothermal Titration Calorimetry (ITC)
            5. X-ray Crystallography
            6. Surface Plasmon Resonance
            7. Mass Spectrometry
            8. Capillary Electrophoresis
            9. Other Biophysical Techniques, Non-biophysical Techniques)
          2. Non-Biophysical Techniques 
        2. Fragment Optimization 
        3. Biopharmaceutical Companies
        4. CROs
        5. Academic and Research Institutions
        6. Oncology
        7. Central Nervous System (CNS) Disorders
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Disorders
        11. Inflammation and Autoimmune Diseases
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.